Back to Selection     Print       Date : 31 Mar 2026
Fund Summary
SBI Large & Midcap Fund Reg (G)
[Equity: Large & Mid Cap]  
 
Fund Details
Fund Type Growth Launch Date 28-Feb-93
Corpus(Cr.) 34871.0 Latest NAV 629.1944 As on 29-04-2026
Equity(%) 92.97 52 Week High 662.381
Debt(%) 5.93 52 Week Low 575.495
Others(%) 0.0 Exit Load 0.1% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 1.57
Scheme Benchmark NIFTY Large Midcap 250 TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Saurabh Pant
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to provide the investor with the opportunity of long-term capital appreciation by investing in diversified portfolio comprising predominantly large cap and mid cap companies.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 21.74%
Top 10 Holdings 34.76%
Top 25 Holdings 63.76%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Banking & Financial 18.23
Pharma & Biotech 12.85
Automobile 8.58
Software & Services 5.73
Cash 5.12
Consumer Durables 4.9
Agricultural & Farm Machinery 4.74
Construction 4.44
Ferrous Metals 4.16
Petroleum Products 3.83
Retail 3.46
Industrial Products 2.71
Chemicals 2.69
Energy 2.41
Food Beverage & Tobacco 2.2
Personal Products 2.06
Telecom 1.69
Metals 1.55
Textiles 1.34
SERVICES 1.19
FMCG 1.18
Global Equity 1.1
Miscellaneous 0.89
Transportation 0.89
SOV 0.81
Finance & Investments 0.56
Healthcare 0.49
Electricals 0.19
Oil & GAS 0.01
 
 
 
 
 
Portfolio Metrics
PB Ratio 3.19
PE Ratio 24.42
 
Top 25 Holdings
Holdings Net Asset(%)
TREPS 6.25
HDFC Bank Limited 6.08
State Bank of India 3.23
Bharat Forge Limited 3.12
Axis Bank Limited 3.06
Reliance Industries Limited 2.93
ICICI Bank Limited 2.87
Ashok Leyland Ltd 2.48
ASIAN PAINTS (INDIA) LTD. 2.39
Berger Paints (I) Limited 2.35
Jindal Steel & Power Limited 2.27
Tata Motors Commercial Vehicles Limited 2.26
Alkem Laboratories Limited 2.24
Shree Cement Limited 2.21
Colgate - Palmolive (India) Ltd. 2.13
Biocon Limited 2.07
Abbott India Limited 2.04
Aurobindo Pharma Limited 2.02
Torrent Power Limited 1.89
ICICI Prudential AMC Ltd 1.77
Balkrishna Industries Limited 1.73
Indus Towers Limited 1.69
United Breweries Limited 1.68
Gland Pharma Limited 1.54
Hexaware Technologies Limited 1.46

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
8.69% -1.85% -1.98% 7.77%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
8.29% -4.81% -7.02% 0.47%
 
Scheme Benchmark [NSE - Nifty Large Midcap 250 TRI]
12.05% 0.04% -2.68% 6.83%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
8.37% 16.37% 16.55% 15.17%
 
 
4.57% 11.46% 11.45% 13.27%
 
 
7.00% 18.44% 16.16% 16.18%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
SBI Large & Midcap Fund Reg (G) 13.16% 0.6184 10.8976% 41.8231 0.0996
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
SBI Large & Midcap Fund Reg (G) 5.0539% 0.0004 0.1028 6.3703 0.9504
 
Back to Selection